- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD1775
Total 102 results
-
NYU Langone HealthTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | MyelofibrosesUnited States
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid TumoursUnited States, United Kingdom
-
ArdelyxCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaTerminatedPreviously Treated Non Small Cell Lung CancerUnited States
-
ArdelyxCompletedHyperphosphatemiaUnited States, Poland, United Kingdom, Slovakia
-
AstraZenecaCompletedAtrial FibrillationSweden, Czech Republic, Hungary, Poland, Netherlands, Norway, Denmark, Slovakia
-
AstraZenecaCompletedAtrial FibrillationRussian Federation, Poland, Denmark, Norway, Slovakia, Sweden
-
AstraZenecaTerminatedHealthy VolunteersUnited Kingdom
-
AstraZenecaCompletedOvarian Cancer | Locally Advanced Solid Tumours | Metastatic Solid TumoursUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaParexelCompletedUterine Serous CarcinomaUnited States, Italy, Spain, France, Canada
-
ArdelyxAstraZenecaCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaTerminated
-
Samsung Medical CenterTerminated
-
AstraZenecaParexelNot yet recruiting
-
AstraZenecaNational Institute of Mental Health (NIMH)CompletedTreatment Resistant Major Depressive DisorderUnited States
-
ArdelyxAstraZenecaCompletedEnd Stage Renal Disease | ESRD | Chronic Kidney Disease Stage 5United States
-
AstraZenecaParexelRecruiting
-
Dana-Farber Cancer InstituteAstraZenecaActive, not recruitingUterine CancerUnited States
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
AstraZenecaQuintiles, Inc.CompletedSolid TumoursFrance, United Kingdom, Netherlands
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
AstraZenecaCompletedMajor Depressive DisorderUnited Kingdom
-
ArdelyxAstraZenecaCompletedHealthy VolunteerUnited States
-
AstraZenecaTerminatedPreviously Untreated Stage IV Non-Squamous Non Small Cell Lung CancerUnited States
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
ArdelyxCompleted
-
ArdelyxCompleted
-
ArdelyxCompletedConstipation Predominant Irritable Bowel SyndromeUnited States
-
AstraZenecaCompletedSeptic Shock | Severe SepsisCzech Republic, France, Spain, Finland, Canada, Australia, Belgium
-
National Cancer Institute (NCI)Completed
-
St. Joseph's Hospital and Medical Center, PhoenixBarbara Ann Karmanos Cancer Institute; American Society of Clinical Oncology; Translational Genomics Research Institute and other collaboratorsCompleted
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Locally Advanced Malignant Solid Neoplasm | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Locally Advanced Clear Cell Renal Cell CarcinomaUnited States
-
ArdelyxCompletedHealthy Volunteers Food Interaction StudyUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
University of BirminghamAstraZeneca; Cancer Research UKCompletedLarynx Cancer | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell CarcinomaUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid TumoursJapan